Table 3. Medical information and Helicobacter pylori eradication rate of standard triple therapy among patients in selected healthcare institutions at Bahir Dar City Administration, May 2016 to April 2018 (n = 421).
| Variables and Categories | Frequency and percentage | Eradication Rate in % |
|
|---|---|---|---|
| Variable | Variable categories | ||
| Outcome of triple therapy | Eradication succeeded | 379 (90.02) | 90.02 |
| Eradication failed | 42(9.98) | 9.98 | |
| Time elapsed since gastritis started | < 1 month | 67(15.9) | 92.5 |
| >1 to 3 months | 116(27.6) | 91.4 | |
| > 3 months | 238(56.5) | 88.7 | |
| Previous history of gastritis therapy | Yes | 235(55.8) | 88.9 |
| No | 186(44.2) | 91.4 | |
| Presence of other chronic disease(s) | Yes | 108(25.6) | 89.7 |
| No | 313(74.3) | 90.7 | |
| Self-reported alcohol intake | Yes | 237(56.3) | 90.3 |
| No | 184(43.7) | 89.7 | |
| Pain feeling period in the day | After meal | 217(51.5) | 90.3 |
| Persistent in the day | 122(29.0) | 88.5 | |
| Long interval between meals | 82(19.5) | 91.5 | |
| Use of Flaxseed or Fenugreek | Yes | 135(32.1) | 86.7 |
| No | 286(67.9) | 91.5 | |
| Triple therapy regimen durations | 10 day Amoxa + Clari + PPI | 279(66.3) | 89.8 |
| 14 day Amoxa + Clari + PPI | 142(33.7) | 91.5 | |
| Self-reported adverse drug effects | Yes | 110(26.1) | 81.8 |
| No | 311(73.9) | 92.9 | |